Skip to main content
. 2012 Nov 29;2012:721612. doi: 10.5402/2012/721612

Table 2.

Morphometric analysis of liver tissue in healthy mice and mice with RLS40 after the treatment under Scheme  2.

PCHT courses, number Days after treatment Hepatocyte degeneration, Vv, % (Mean ± SEM) Hepatocyte necrosis, Vv, % (Mean ± SEM) Volume density of hepatic lymphoma infiltration, Vv, %
Healthy mice Mice with RLS40 Healthy mice Mice with RLS40
(n = 45) (n = 45) (n = 45) (n = 45)
Baseline#    7.3 ± 0.7 12.6 ± 1*    3.1 ± 0.5 12.1 ± 1*

1 1 33.7 ± 2.2 40.7 ± 3.2 17.1 ± 1.1 13.5 ± 1.2*
3 24 ± 2.1 20.6 ± 1.6 16.4 ± 1.4 19.2 ± 1.3
7 15.7 ± 0.9 27.7 ± 1.6* 12.6 ± 1 18 ± 1.35* 15 ± 4

2 1 27.5 ± 1.5 25.9 ± 1.2 19.7 ± 1.7 24 ± 1*
3 26.6 ± 1.7 40.7 ± 2.1* 17.6 ± 1.4 20.8 ± 1.3
7 31.4 ± 1.8 29.6 ± 1.9 17 ± 1 37.9 ± 3.7* 26 ± 4

3 1 27.2 ± 1.2 34.3 ± 3* 13.6 ± 1.3 40.8 ± 3.6*
3 27.9 ± 1.3 36.9 ± 2.6*    9.6 ± 0.9 47.7 ± 4.1* 30 ± 5
7 28.7 ± 1.2 22.9 ± 1.2

*P ≤ 0.05 compared to healthy mice.

#Initial level determined just before treatment (6th day after tumor transplantation).